| [1] |
Buchwald H. The evolution of metabolic/bariatric surgery[J]. Obesity surgery, 2014, 24(8): 1126-1135.
|
| [2] |
Marceau P, Biron S, Marceau S, et al. Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion[J]. ObesSurg, 2015, 25(9): 1584-1593.
|
| [3] |
Skogar ML, Sundbom M. Duodenal switch is superior to gastric bypass in patients with super obesity when evaluated with the bariatric analysis and reporting outcome system (BAROS)[J]. Obesity surgery, 2017, 27(9): 2308-2316.
|
| [4] |
Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures[J]. Obesity surgery, 2018, 28(12): 3783-3794.
|
| [5] |
Jiménez A, Ceriello A, Casamitjana R, et al. Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile[J]. Annals of surgery, 2015, 261(2): 316-322.
|
| [6] |
Dogan K, Betzel B, Homan J, et al. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients[J]. Obesity surgery, 2014, 24(11): 1835-1842.
|
| [7] |
Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass[J]. Obesity surgery, 2013, 23(1): 93-102.
|
| [8] |
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis[J]. The American journal of medicine. 2009, 122(3): 248-256.
|
| [9] |
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery[J]. N Engl J Med, 2004, 351(26): 2683-2693.
|
| [10] |
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients[J]. Annals of surgical, 2004, 240(3): 416-423.
|
| [11] |
Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss[J]. Annals of surgical, 2003, 237(6): 751-756.
|
| [12] |
Weiner RA, Theodoridou S, Weiner S. Failure of laparoscopic sleeve gastrectomy—further procedure?[J]. Obesity Facts, 2011, 4 (1): 42-46.
|
| [13] |
Brian M, Daniel C, Richie G, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience[J]. Obesity surgery, 2016, 26(9): 2098-2104.
|
| [14] |
Csendes A, Burgos AM, Smok G, et al. Latest results (12-21 years) of a prospective randomized study comparing Billroth II and Roux-en-Y anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers[J]. Annals of surgical, 2009, 249(2): 189-194.
|
| [15] |
Tu BL, Kelly KA. Surgical treatment of Roux stasis syndrome[J]. Journal of gastrointestinal surgery, 1999, 3(6): 613-617.
|
| [16] |
Sanchez-Pernaute A, Herrera MA, Perez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADIS): One to three-year follow-up[J]. Obesity surgery, 2010, 20(12): 1720-1726.
|
| [17] |
Bo TN, Bleu S, Daniel RC, et al. Stomach intestinal pylorus-sparing surgery for morbid obesity[J]. Journal of the society of laparoendoscopic surgeons, 2018, 22(1): e2017.00063.
|
| [18] |
Risstad H, Sovik TT, Engstrom M, et al. Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial[J]. The Journal of the American medical association, 2015, 150(4): 352-361.
|
| [19] |
Cottam A, Cottam D, Medlin W, et al. A matched cohort analysis of single anastomosis loop duodenal switch versus Roux-en-Y gastric bypass with 18-month follow-up[J]. Surgical endoscopy, 2015, 30(9): 3958-3964.
|